Arch Therapeutics Inc (ARTH)
1.48
0.00 (0.00%)
USD |
OTCM |
May 21, 11:06
Arch Therapeutics Gross Profit Margin (Quarterly): 32.36% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 32.36% |
| December 31, 2023 | 48.53% |
| September 30, 2023 | 41.09% |
| June 30, 2023 | -39.39% |
| March 31, 2023 | -12.39% |
| December 31, 2022 | -181.7% |
| September 30, 2022 | 91.95% |
| Date | Value |
|---|---|
| June 30, 2022 | -173.8% |
| March 31, 2022 | -456.9% |
| December 31, 2021 | -257.6% |
| September 30, 2021 | -933.9% |
| June 30, 2021 | |
| March 31, 2021 | -1.02% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-933.9%
Minimum
Sep 2021
91.95%
Maximum
Sep 2022
-153.6%
Average
-25.89%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 74.85% |
| Xtant Medical Holdings Inc | 62.07% |
| Asensus Surgical Inc | -172.1% |
| Senseonics Holdings Inc | 6.64% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -497.3% |
| Profit Margin (Quarterly) | -4.61K% |
| Operating Margin (Quarterly) | -2.75K% |
| Return on Net Operating Assets | -569.7% |